Related Experiment Video
Updated: Apr 23, 2026
10:05
The Multi-organ Chip - A Microfluidic Platform for Long-term Multi-tissue Coculture
Published on: April 28, 2015
32.0K
Microengineering the Liver: Strategies for Constructing Functional Liver-on-a-Chip Devices.
Jie Wang1, Ziwei Liang1,2,3,4, Jiapu Wang1
1Department of Biomedical Engineering Research Center for Nano-Biomaterials & Regenerative Medicine College of Artificial Intelligence Shanxi Key Laboratory of Materials Strength & Structural Impact Taiyuan University of Technology Taiyuan China.
Exploration (Beijing, China)
|April 22, 2026
Summary
Liver-on-a-chip (LOC) technology offers advanced in vitro models for liver research. These microfluidic devices better mimic human liver physiology, improving drug screening and disease modeling compared to traditional methods.
Area of Science:
- Biomedical Engineering
- Organ-on-a-chip Technology
- Liver Physiology Research
Background:
- Current 2D/3D cell cultures and animal models fail to accurately replicate human liver microenvironments and in vivo conditions.
- Limitations include impaired cellular functions, lack of tissue-like architecture, species differences, and ethical concerns with animal models.
- There is a critical need for advanced in vitro models that recapitulate human liver pathophysiology for drug development and disease research.
Purpose of the Study:
- To review recent advancements in Liver-on-a-chip (LOC) technologies.
- To highlight innovative strategies in biomimetic tissue engineering, extracellular matrix construction, and microphysiological systems.
- To discuss the integration of emerging technologies for enhanced physiological relevance and monitoring.
Main Methods:
- Review of recent literature on microfluidic-based Liver-on-a-chip systems.
- Analysis of strategies for biomimetic tissue construction, including 3D bioprinting, vascularization, and incorporation of liver buds/organoids.
- Discussion of sensor integration and deep learning for real-time monitoring.
Main Results:
- LOC technology enables the replication of liver microstructures and tissue interfaces, simulating organ-level physiological activities.
- Advances include enhanced biomimetic designs, 3D bioprinting, vascularization, and organoid integration for greater accuracy.
- Integration of deep learning and sensors allows for intelligent, real-time monitoring of liver functions within LOC devices.
Conclusions:
- Liver-on-a-chip technology represents a significant breakthrough in developing physiologically relevant in vitro liver models.
- These models show great promise for improving drug screening accuracy and advancing liver disease modeling.
- Further development and clinical translation of LOC technology are crucial for personalized medicine and biomedical research.
